XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.22

-5.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Walter R. Roche who wrote (6326)	5/19/1998 10:18:00 AM
From: aknahow	of 17367

Walter, check out Jesse Eisinger's story on IDEC & Coulter at TSC or thestreet.com. Date 18 May. Must reading. Think it provides enough information that one concludes it still is not clear that Rituxan will be a smashing success. Just think of the compounding on the $17 million received and you may feel better about the sale of the rights, but only if you read the article. If URL does not work just go to thestreet.com. thestreet.com The URL is correct and works if you are registered. Don't know how or if it works if not registered. To anyone who can't afford $70 a year for thestreet, GET OUT OF THE MARKET!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next